Human beta 3 Adrenergic Receptor (ADRB3) activation kit by CRISPRa

CAT#: GA100108

ADRB3 CRISPRa kit - CRISPR gene activation of human adrenoceptor beta 3



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (2)
ADRB3 Rabbit polyclonal Antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00

热销推荐


ADRB3 (Myc-DDK-tagged)-Human adrenergic, beta-3-, receptor (ADRB3)
    • 10 ug

CNY 3,656.00
CNY 3,990.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol ADRB3
Locus ID 155
Kit Components

GA100108G1, beta 3 Adrenergic Receptor gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA100108G2, beta 3 Adrenergic Receptor gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA100108G3, beta 3 Adrenergic Receptor gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_000025
Synonyms BETA3AR
Summary The protein encoded by this gene belongs to the family of beta adrenergic receptors, which mediate catecholamine-induced activation of adenylate cyclase through the action of G proteins. This receptor is located mainly in the adipose tissue and is involved in the regulation of lipolysis and thermogenesis. Obesity and bodyweight-related disorders are correlated with certain polymorphisms in three subtypes of beta-adrenoceptor, among them, the ADRB3 gene.[provided by RefSeq, Oct 2019]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...